- Home
- AREC vs MRSN Comparison
AREC vs MRSN Comparison
Compare AREC & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AREC
- MRSN
- Stock Information
- Founded
- AREC 2013
- MRSN 2001
- Country
- AREC United States
- MRSN United States
- Employees
- AREC N/A
- MRSN N/A
- Industry
- AREC Coal Mining
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- AREC Energy
- MRSN Health Care
- Exchange
- AREC Nasdaq
- MRSN Nasdaq
- Market Cap
- AREC 37.9M
- MRSN 40.7M
- IPO Year
- AREC 2019
- MRSN 2017
- Fundamental
- Price
- AREC $0.85
- MRSN $0.32
- Analyst Decision
- AREC Strong Buy
- MRSN Buy
- Analyst Count
- AREC 3
- MRSN 3
- Target Price
- AREC $4.33
- MRSN $4.00
- AVG Volume (30 Days)
- AREC 14.8M
- MRSN 2.3M
- Earning Date
- AREC 05-20-2025
- MRSN 05-15-2025
- Dividend Yield
- AREC N/A
- MRSN N/A
- EPS Growth
- AREC N/A
- MRSN N/A
- EPS
- AREC N/A
- MRSN N/A
- Revenue
- AREC $399,962.00
- MRSN $40,497,000.00
- Revenue This Year
- AREC N/A
- MRSN N/A
- Revenue Next Year
- AREC $3,208.62
- MRSN N/A
- P/E Ratio
- AREC N/A
- MRSN N/A
- Revenue Growth
- AREC N/A
- MRSN 9.88
- 52 Week Low
- AREC $0.38
- MRSN $0.26
- 52 Week High
- AREC $1.68
- MRSN $3.50
- Technical
- Relative Strength Index (RSI)
- AREC 51.53
- MRSN 41.87
- Support Level
- AREC $0.72
- MRSN $0.35
- Resistance Level
- AREC $1.08
- MRSN $0.44
- Average True Range (ATR)
- AREC 0.12
- MRSN 0.04
- MACD
- AREC -0.03
- MRSN -0.00
- Stochastic Oscillator
- AREC 21.67
- MRSN 8.48
About AREC American Resources Corporation
American Resources Corp is a next-generation, environmentally, and socially responsible supplier of high-quality raw materials to the new infrastructure market. The firm is focused on the extraction and processing of metallurgical carbon, an essential ingredient used in steelmaking, critical and rare earth minerals for the electrification market, and reprocessed metal to be recycled. The firm has a growing portfolio of operations located in the Central Appalachian basin of eastern Kentucky and southern West Virginia where premium quality metallurgical carbon and rare earth mineral deposits are concentrated. Its business model provides a significant opportunity to scale its portfolio of assets to meet the growing global infrastructure and electrification markets.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.